Is Probiotics Acne Randomized Trial safe?

Updated August 2026

Quick Answer

Probiotics Acne Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Standard therapy often relies on antibiotics, but the long-term use has increased antibiotic resistance, including in Indonesia.

Key Takeaways

  • 01Standard therapy often relies on antibiotics, but the long-term use has increased antibiotic resistance, including in Indonesia. [Lestari K (2026)]
  • 02Background Acne vulgaris is a chronic inflammatory condition primarily caused by Cutibacterium acnes , which disrupts skin homeostasis, thereby triggering immune responses and sebum metabolism. [Lestari K (2026)]
  • 03Dysbiosis is an imbalance in the skin and gut microbiota identified as a significant factor contributing to acne progression. [Lestari K (2026)]
  • 04These treatments show varying degrees of efficacy and improved safety profiles, but most lack head-to-head comparisons with isotretinoin. [Tommasino N (2026)]
The current Migaku evidence database contains 2 reusable source documents for Probiotics Acne Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Standard therapy often relies on antibiotics, but the long-term use has increased antibiotic resistance, including in Indonesia. [Lestari K (2026); evidence level 2] - Background Acne vulgaris is a chronic inflammatory condition primarily caused by Cutibacterium acnes , which disrupts skin homeostasis, thereby triggering immune responses and sebum metabolism. [Lestari K (2026); evidence level 2] - Dysbiosis is an imbalance in the skin and gut microbiota identified as a significant factor contributing to acne progression. [Lestari K (2026); evidence level 2] - These treatments show varying degrees of efficacy and improved safety profiles, but most lack head-to-head comparisons with isotretinoin. [Tommasino N (2026); evidence level 4] - Conclusion Several systemic options beyond isotretinoin have emerged, showing potential in specific subgroups or as adjunctive therapies. [Tommasino N (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Oral probiotics and topical secretome to enhance clinical outcomes and microbiome restoration in acne vulgaris: a double-blind, randomised controlled trial protocol.
  2. Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate-to-Severe Acne.